๐ฐ Abstracts News
Page 9 - Abstracts News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abstracts. Real-time updates on events, politics, business and more.
February 15, 2022
See what was happening in the Manistee News Advocate 100 years ago.ย
February 4, 2022
The Organization for Safety, Asepsis and Prevention (OSAP) said abstracts for its annual conference are due February 4.
January 17, 2022
TOKYO, Jan 17, 2022 - (JCN Newswire) - Eisai Co., Ltd. announced today that presentations on a series of abstracts highlighting updates on its in-house discovered lenvatinib mesylate (product name: LENVIMA
January 11, 2022
Fusion Art is pleased to announce the opening of the 7th Annual Artistโs Choice International Art Exhibition. The exhibition is now available for viewing on the Fusion Art website and ...
December 14, 2021
A journey in abstracts, a freshly found passion, and there a new artist in town. Dr Shefali Bhujbal, a dilettante artist, has displayed her artworks in the Bo
November 4, 2021
CHICAGO, Oct. 29, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) today announced the presentation of new award-winning abstracts supporting the many benefits of Elekta Unity in treating cancer patients
November 4, 2021
Several presentations will highlight broad potential of CD19-targeted ADC ZYNLONTA (loncastuximab tesirine-lpyl) as a single agent and in combination for the treatment of non-Hodgkin lymphomas ADC
November 4, 2021
Poster presentations highlighting safety and preliminary efficacy data of epcoritamab (DuoBody-CD3xCD20) in combination with other treatments in patients with B-cell non-Hodgkin lymphoma (NHL)
November 4, 2021
Numerous oral presentations highlighting data for tafasitamab, parsaclisib, ruxolitinib, pemigatinib, itacitinib and ponatinib to be highlighted during the Congress Incyte (Nasdaq:INCY) today announced
October 29, 2021
CHICAGO, Oct. 29, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) today announced the presentation of new award-winning abstracts supporting the many benefits of Elekta Unity in treating cancer patients